Qalsody 100 MG/15 ML vial 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMEB8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,978
Award facts
- Contract value 100% obligated
- $21,978.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $21,978.02 to DMS Pharmaceutical Group Inc. for QALSODY 100 mg/15 mL vials on December 15, 2025. The award is scheduled for completion by January 7, 2026, with performance taking place at the vendor's headquarters in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is fulfilling this requirement under its indefinite delivery contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which was awarded on November 13, 2025, with a $499.9 billion ceiling value through December 31, 2036. The company serves as a critical regional pharmaceutical supplier supporting Department of Defense medical supply chain operations globally, providing a comprehensive portfolio of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities. This delivery order represents a routine pharmaceutical supply transaction within the broader $30.3 billion PPV-G GEN V acquisition strategy established by the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FMEB8?
SPE2DR26FMEB8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FMEB8 worth?
The government has obligated $21,978 on SPE2DR26FMEB8.
Is contract SPE2DR26FMEB8 an order under another contract?
Yes. SPE2DR26FMEB8 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEB8 competed?
The extent of competition for SPE2DR26FMEB8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award